Hemodynamic Effects of Methylene Blue vs Hydroxocobalamin in Patients at Risk of Vasoplegia During Cardiac Surgery
Status:
Withdrawn
Trial end date:
2020-06-30
Target enrollment:
Participant gender:
Summary
This is a pilot study to determine the hemodynamic effects when hydroxocobalamin vs methylene
blue is administered during cardiopulmonary bypass in patients at risk of vasoplegia by
measuring mean arterial pressure (MAP), systemic vascular resistance (SVR) and vasopressor
requirement.